Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01111591
Recruitment Status : Enrolling by invitation
First Posted : April 27, 2010
Last Update Posted : October 28, 2016
Seoul National University Bundang Hospital
Information provided by (Responsible Party):
Ho-Seong Han, Seoul National University Hospital